Article Information
vol. 4 no. 150 150ra121
- Received for publication May 29, 2012
- Accepted for publication July 20, 2012
- .
Author Information
- João Neres1,2,3,
- Florence Pojer1,2,
- Elisabetta Molteni1,4,
- Laurent R. Chiarelli1,4,
- Neeraj Dhar1,2,
- Stefanie Boy-Röttger1,2,
- Silvia Buroni1,4,
- Elizabeth Fullam1,2,*,
- Giulia Degiacomi1,4,†,
- Anna Paola Lucarelli4,‡,
- Randy J. Read5,
- Giuseppe Zanoni6,
- Dale E. Edmondson7,
- Edda De Rossi1,4,
- Maria Rosalia Pasca1,4,
- John D. McKinney1,2,
- Paul J. Dyson3,
- Giovanna Riccardi1,4,
- Andrea Mattevi4,
- Stewart T. Cole1,2,§ and
- Claudia Binda1,4,§
- 1More Medicines for Tuberculosis (MM4TB) Consortium.
- 2Global Health Institute, École Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.
- 3Institute of Chemical Sciences and Engineering, École Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.
- 4Department of Biology and Biotechnology, University of Pavia, Via Ferrata 9, 27100 Pavia, Italy.
- 5Department of Haematology, University of Cambridge, Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, Hills Road, Cambridge CB2 0XY, UK.
- 6Department of Chemistry, University of Pavia, Via Taramelli 12, 27100 Pavia, Italy.
- 7Department of Biochemistry, Emory University, Atlanta, GA 30322, USA.
- ↵§To whom correspondence should be addressed. E-mail: claudia.binda{at}unipv.it (C.B.); stewart.cole{at}epfl.ch (S.T.C.)